The global disposable endoscopes market, valued at $2.58 billion in 2025, is projected to grow to $10.47 billion by 2035 with a CAGR of 15.04%. Growth is fueled by rising demand for single-use endoscopes, infection prevention efforts, and increased use of minimally invasive procedures. North America leads the market, while Asia Pacific shows the fastest growth due to expanding healthcare infrastructure and awareness. Key segments include bronchoscopes and gastrointestinal endoscopes, with hospitals as the primary end users.
Noble Capital Markets has initiated equity research coverage on VivoPower PLC, assigning an Outperform rating and setting a price target of $10. VivoPower is a B Corp-certified global developer of powered land and data center infrastructure for AI ap...
The head and neck squamous cell carcinoma (HNSCC) market is projected to grow at a 10.5% CAGR from 2026 to 2036, driven by rising cancer incidence and new immunotherapy launches. Key emerging therapies from companies like Johnson & Johnson, BioNTech,...
Alamar Biosciences has partnered with top U.S. research universities to start a nationwide proteomics project using its NULISAseq™ Neuro 220 panel. The study will analyze about 21,000 plasma samples from 10,000 Alzheimer's and related dementia partic...
Alamar Biosciences has partnered with leading U.S. universities to launch a nationwide proteomics study analyzing around 21,000 plasma samples from 10,000 Alzheimer's and related dementia patients. Using its NULISAseq™ Neuro 220 test kit, the project...
VINCI SA announced it repurchased a total of 400,000 treasury shares from July 6 to July 10, 2026, under authorization from its April 2026 General Meeting. The shares were bought at an average weighted price of approximately €120.99 per share across ...
